JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Scope & Guideline
Unraveling the complexities of heart health through science.
Introduction
Aims and Scopes
- Molecular Mechanisms in Cardiac Function:
Research on the molecular pathways that regulate cardiac function, including signaling cascades, gene expression, and metabolic processes that influence heart health. - Cardiovascular Disease Mechanisms:
Studies exploring the pathophysiology of various cardiovascular diseases such as heart failure, arrhythmias, and cardiomyopathies, emphasizing the cellular and molecular alterations involved. - Innovative Therapeutic Strategies:
Development and evaluation of novel therapeutic approaches, including gene therapy, stem cell therapy, and pharmacological interventions aimed at repairing or regenerating cardiac tissue. - Cardiac Regeneration and Repair:
Research focused on the mechanisms underlying cardiac regeneration, including the role of stem cells, extracellular matrix, and signaling pathways in promoting tissue repair. - Sex Differences in Cardiovascular Health:
Investigation of how biological sex influences cardiovascular health, disease prevalence, and treatment response, with a focus on molecular and cellular differences. - Integrative Omics Approaches:
Utilization of multi-omics technologies (genomics, proteomics, metabolomics) to provide comprehensive insights into cardiovascular biology and disease mechanisms.
Trending and Emerging
- Cardiovascular Metabolism:
An increasing focus on the role of metabolic pathways in cardiac health and disease, particularly how metabolic dysregulation contributes to conditions such as obesity, diabetes, and heart failure. - Gene Editing and Gene Therapy:
A surge in research utilizing CRISPR and other gene editing technologies to explore genetic underpinnings of cardiovascular diseases and develop targeted gene therapies. - Extracellular Vesicles and Cell Communication:
Emerging studies investigating the role of extracellular vesicles in intercellular communication and their potential as biomarkers or therapeutic agents in cardiovascular diseases. - Inflammation and Immunology in Cardiology:
Growing interest in understanding the immune response in cardiovascular diseases, particularly how inflammation contributes to disease progression and the potential for immunomodulatory therapies. - Single-Cell and Multi-Omics Approaches:
The adoption of single-cell sequencing and integrative multi-omics approaches is on the rise, allowing for a more detailed understanding of cellular heterogeneity and the molecular landscape of cardiovascular diseases. - Personalized Medicine and Cardiovascular Health:
A trend towards personalized approaches to cardiovascular disease management, incorporating genetic, molecular, and clinical data to tailor treatments to individual patients.
Declining or Waning
- Traditional Pharmacology:
There is a noticeable reduction in studies centered on traditional pharmacological approaches to treating heart disease, as the field shifts towards more innovative and targeted therapeutic strategies. - Basic Animal Models:
Research using basic animal models without advanced genetic manipulations or disease modeling techniques has decreased, reflecting a broader trend towards more sophisticated and translational modeling approaches. - Cardiac Imaging Techniques:
While imaging remains a crucial tool in cardiology, there is less emphasis on traditional imaging studies (e.g., echocardiography) in favor of molecular and cellular investigations that provide deeper mechanistic insights. - Aging Research in Cardiovascular Disease:
Although aging is a critical factor in cardiovascular health, publications specifically addressing aging-related mechanisms in a standalone manner have diminished, likely due to a shift towards integrated approaches that consider aging as a variable within broader studies.
Similar Journals
BASIC RESEARCH IN CARDIOLOGY
Exploring the frontiers of basic and translational cardiology.BASIC RESEARCH IN CARDIOLOGY, published by SPRINGER HEIDELBERG, is an esteemed peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine since 1973. With a strong emphasis on the latest breakthroughs in basic and translational research, this journal offers a platform for high-quality, impactful studies that contribute to our understanding of cardiac function and related physiological processes. Currently ranked in the Q1 category in Cardiology and Cardiovascular Medicine, as well as Physiology and Medical Physiology, BASIC RESEARCH IN CARDIOLOGY is recognized as a leading journal within these disciplines, boasting impressive Scopus ranks that place it in the top tiers of global research output. While it does not offer open access, its contributions are pivotal for researchers, clinicians, and students seeking to stay abreast of cutting-edge discoveries and methodologies in cardiovascular science. With its commitment to scholarly excellence, this journal plays a critical role in shaping the future of cardiac research and clinical practice.
Frontiers in Physiology
Pioneering research at the intersection of physiology and medicine.Frontiers in Physiology, published by FRONTIERS MEDIA SA, is a leading open-access journal that has been at the forefront of physiological research since its inception in 2010. As a reputable publication based in Switzerland, it aims to foster the dissemination of groundbreaking findings across various domains of physiology, engaging a global audience of scholars and practitioners. With a commendable Q2 ranking in the fields of both general physiology and medical physiology for 2023, this journal stands out in its field, achieving a significant Scopus rank of #32/113 in medical physiology and #58/193 in biochemistry, genetics, and molecular biology. Frontiers in Physiology not only commits to maintaining high scholarly standards but also ensures that all its articles are freely accessible, thereby promoting collaborative knowledge exchange. With a clear focus on advancing our understanding of physiological processes, the journal plays a crucial role in the development of innovative approaches to health and disease, making it an essential resource for researchers, professionals, and students alike.
Cardiogenetics
Empowering the future of personalized cardiology through genetics.Cardiogenetics, published by MDPI, is a leading open-access journal dedicated to advancing the field of genetics as it pertains to cardiovascular health and diseases. Since its launch in 2011, this journal has been at the forefront of disseminating high-quality research that explores the genetic underpinnings of cardiovascular conditions, offering a platform for innovative studies, reviews, and case reports. With an ISSN of 2035-8253 and an E-ISSN of 2035-8148, Cardiogenetics aims to bridge the gap between genetic research and clinical application, helping researchers, healthcare professionals, and students stay abreast of the latest advancements and findings. The journal’s commitment to open access ensures that its valuable content is available to a global audience, fostering greater collaboration and knowledge sharing in the cardiovascular genetics community. By contributing to this dynamic field, Cardiogenetics plays a crucial role in improving patient outcomes and paving the way for personalized medicine in cardiology.
DEVELOPMENTAL CELL
Charting New Pathways in Biochemistry and GeneticsDEVELOPMENTAL CELL, published by CELL PRESS, stands as a premier journal in the fields of Biochemistry, Genetics and Molecular Biology, Cell Biology, and Developmental Biology. With a significant influence evidenced by its Q1 rankings across several categories in 2023 and a remarkable Scopus ranking placing it at the 98th percentile for Developmental Biology, this journal is pivotal for researchers and academics aiming to advance their understanding of cellular processes. Covering a broad range of topics from molecular mechanisms to cellular developmental pathways, DEVELOPMENTAL CELL publishes cutting-edge research articles that contribute to the dynamic landscape of cell biology and related disciplines. Although it does not currently offer open access, the journal is accessible through institutional subscriptions, reinforcing its commitment to disseminating high-quality scientific knowledge produced by leading experts in the field. Based in the United States, DEVELOPMENTAL CELL continues to push the boundaries of discovery and innovation in life sciences, making it an essential resource for professionals, researchers, and students alike in the quest for foundational biological insights.
CELLULAR SIGNALLING
Exploring the Intricacies of Cell BiologyCELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.
ACTA CARDIOLOGICA
Advancing cardiovascular knowledge since 1946.ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.
Current Opinion in Physiology
Shaping Tomorrow’s Understanding of PhysiologyCurrent Opinion in Physiology, published by Elsevier, is a leading journal dedicated to the dynamic field of physiology. With an E-ISSN of 2468-8673, this journal provides a platform for the latest insights and perspectives, reflecting the evolving landscape of physiological research. Operating from the United Kingdom, the journal holds a respectable impact factor and is ranked Q2 in both general physiology and medical physiology categories, highlighting its prominence among the global academic community. With Scopus rankings placing it in the 64th and 60th percentiles within its respective categories, Current Opinion in Physiology serves as an essential resource for researchers, professionals, and students eager to stay informed about innovative theories and emerging trends in physiology. The publication emphasizes high-quality reviews that summarize current knowledge and future directions, ensuring readers gain valuable insights applicable in both clinical and research settings.
Journal fur Kardiologie
Exploring the Heart of Cardiovascular Research.The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.
Revista Portuguesa de Cardiologia
Exploring innovative solutions in cardiology since 1970.Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.
Revista de la Federacion Argentina de Cardiologia
Advancing cardiovascular knowledge for a healthier tomorrow.Revista de la Federacion Argentina de Cardiologia is a vital publication in the field of Cardiology and Cardiovascular Medicine, providing a platform for researchers and healthcare professionals to share significant findings and innovative concepts since its inception in 2012. Published by the Federacion Argentina Cardiology, this journal specifically addresses contemporary issues and advancements within cardiology, contributing to the scholarly dialogue essential for improving cardiovascular health. Despite being categorized in the Q4 quartile for 2023 and presently ranking #358 out of 387 in its field, the journal remains committed to fostering academic inquiry and disseminating valuable research for both local and global audiences. Although it is not an open-access journal, it strives to balance accessibility with rigorous academic standards, ensuring quality contributions that are critical for practitioners and students alike. The journal’s ongoing evaluation and adaptation in the ever-evolving landscape of cardiology underscore its importance in advancing cardiovascular science and practice.